1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6FFAB7EA0F5CF6BDA85256EB0005F6A15
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/planning-clinical-trials-targeting-patients-and-study-sites?opendocument
18
19opendocument
203.87.147.184
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Clinical Operations Patient Recruitment and Retention for Clinical trials

Planning Clinical Trials: Targeting Patients and Study Sites

DB Image

ID: 4671


Features:

Graphics


Pages/Slides: 28


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Study Overview

Targeting is the cornerstone of any effective marketing communications. Targeting the appropriate patients and study sites vastly improves the timeliness and efficiency of any pharmaceutical clinical trial. Pharmaceutical companies can use the information in this document to make necessary adjustments to the study protocol and finish trials in a timely manner. This 28-page document details the way top pharmaceutical companies identifiy, profile, review, and select investigators, patients, and study sites that are well-matched with the goals of the study.

Key Topics

  • leveraging marketing and recruitment expertise for trial planning
  • recruitment of the right amount and types of patients
  • reaching and securing patients
  • defining site selection criteria
  • use of diverse sources (internal, external, and publicity generated contacts) in site identification


Sample Best Practices
  • Select contract organizations based on their marketing and recruitment expertise in a study’s given therapeutic area to supplement company capabilities.
    *One company outsources studies that are large, have high visibility, and need to be done quickly. It has plans to bring more studies in-house with a team of internal monitors.
  • Apply market research techniques to analyze trends with the targeted patient population to predict and plan for patient recruitment.
    *One patient recruitment organization recognizes that some factors that impact a site’s ability to recruit may have nothing to do with the site itself but rather with external market conditions in the site’s location. Therefore, the company has developed a macro-determinator tool to look at areas such as the physicians per capita, cost to advertise, and number of newspapers in the area.
  • Apply market research techniques to analyze trends with the targeted patient population to predict and plan for patient recruitment.
    *Having three primary ways to identify study sites for participation in its clinical trials, one company focuses on therapeutic networks, an internal database of preferred providers and its sales force.
Methodology
This research originated from a Best Practices, LLC consulting project.

Industries Profiled:
Research; Pharmaceutical; Medical Device; Biotech; Manufacturing; Consumer Products; Diagnostic; Professional Services; Health Care


Companies Profiled:
America's Doctor; Sanofi-aventis; Roche; aaiPharma; Trimeris; PPD; AstraZeneca; Bayer; BBK Healthcare; Bristol-Myers Squibb; Covance; Eli Lilly; GlaxoSmithKline; Health Decisions; Pfizer


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.